Keyword Analysis & Research: duaklir


Keyword Analysis

Keyword CPC PCC Volume Score Length of keyword
duaklir1.10.15255427

Keyword Research: People who searched duaklir also searched

Keyword CPC PCC Volume Score
duaklir0.840.7810947

Search Results related to duaklir on Search Engine

  • Duaklir Pressair Inhaler: Uses, Dosage, Side Effects, Warnings - Drugs.com

    drugs.com

    https://www.drugs.com/duaklir-pressair.html

    WEBDuaklir Pressair is a prescription medicine used to prevent airflow obstruction and reduce flare-ups in adults with COPD ( chronic obstructive pulmonary disease ), including bronchitis and emphysema. Duaklir Pressair is for use only in people with COPD and should not be used to treat asthma.

    DA: 59 PA: 4 MOZ Rank: 58

  • Duaklir Pressair: Package Insert - Drugs.com

    drugs.com

    https://www.drugs.com/pro/duaklir-pressair.html

    WEBAug 21, 2022 · DUAKLIR PRESSAIR is used long term as 1 inhalation 2 times each day to improve symptoms of COPD for better breathing and to reduce the number of flare-ups (the worsening of your COPD symptoms for several days). • DUAKLIR PRESSAIR is not for use to treat sudden symptoms of COPD.

    DA: 69 PA: 85 MOZ Rank: 86

  • Duaklir Pressair (aclidinium / formoterol): Uses, Side Effects ... - GoodRx

    goodrx.com

    https://www.goodrx.com/duaklir-pressair/what-is

    WEBDec 9, 2021 · Used for COPD. Duaklir Pressair (aclidinium / formoterol) is a combination of two medications in one inhaler that helps control symptoms of chronic obstructive pulmonary disease (COPD) when taken regularly. It doesn't replace a rescue inhaler for sudden symptoms and isn't meant to treat asthma.

    DA: 12 PA: 23 MOZ Rank: 63

  • Duaklir Pressair Dosage Guide - Drugs.com

    drugs.com

    https://www.drugs.com/dosage/duaklir-pressair.html

    WEBJan 15, 2024 · Duaklir Pressair Dosage. Medically reviewed by Drugs.com. Last updated on Jan 15, 2024. The recommended dose of DUAKLIR PRESSAIR is one oral inhalation of 400 mcg/12 mcg, twice daily (once in the morning and once in the evening). Do not take more than one inhalation twice daily.

    DA: 49 PA: 15 MOZ Rank: 35

  • Duaklir Pressair Inhalation: Uses, Side Effects, Interactions ... - WebMD

    webmd.com

    https://www.webmd.com/drugs/2/drug-178032/duaklir-pressair-inhalation/details

    WEBThis product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by ongoing lung disease ( chronic obstructive pulmonary disease - COPD, which includes chronic...

    DA: 87 PA: 37 MOZ Rank: 76

  • Duaklir Genuair | European Medicines Agency

    europa.eu

    https://www.ema.europa.eu/en/medicines/human/EPAR/duaklir-genuair

    WEBDec 5, 2014 · COPD is a long-term disease in which the airways and air sacs inside the lungs become damaged or blocked, leading to difficulty breathing. Duaklir Genuair is used for maintenance (regular) treatment. Duaklir Genuair contains two active substances: aclidinium bromide and formoterol fumarate dihydrate.

    DA: 12 PA: 77 MOZ Rank: 24

  • DUAKLIR PRESSAIR Dosage & Rx Info | Uses, Side Effects

    empr.com

    https://www.empr.com/drug/duaklir-pressair/

    WEBGeneric Availability. NO. Duaklir Pressair Indications. Indications. Maintenance treatment of COPD. Limitations of Use. Not indicated for relief of acute bronchospasm or for treatment of asthma....

    DA: 85 PA: 20 MOZ Rank: 53

  • Aclidinium Bromide and Formoterol Fumarate Approved for COPD

    pulmonologyadvisor.com

    https://www.pulmonologyadvisor.com/home/topics/copd/duaklir-pressair-approved-for-maintenance-treatment-of-copd/

    WEBApr 8, 2019 · Duaklir Pressair combines aclidinium bromide, a long-acting muscarinic antagonist (LAMA), and formoterol fumarate, a long-acting beta 2 -adrenergic agonist (LABA). It is intended for twice-daily use with the breath-actuated Pressair inhaler.

    DA: 44 PA: 2 MOZ Rank: 10

  • Duaklir significantly improves lung function in COPD patients - AstraZeneca

    astrazeneca.com

    https://www.astrazeneca.com/media-centre/press-releases/2017/duaklir-significantly-improves-lung-function-in-copd-patients-07092017.html

    WEBSep 7, 2017 · AstraZeneca today announced positive top-line results from the Phase III AMPLIFY trial for Duaklir* (aclidinium bromide/formoterol 400µg/12µg twice-daily), which met its primary endpoints, demonstrating a statistically-significant improvement in lung function in patients with moderate to very severe stable chronic obstructive pulmonary ...

    DA: 16 PA: 71 MOZ Rank: 51

  • PART III: CONSUMER INFORMATION - AstraZeneca

    astrazeneca.com

    https://www.astrazeneca.com/content/dam/az-ca/downloads/productinformation/duaklir-consumer-information-leaflet-en.pdf

    WEBAug 1, 2019 · DUAKLIR GENUAIR is used long term to help open the airways in adults with breathing difficulties due to a lung disease called chronic obstructive pulmonary disease (COPD). DUAKLIR GENUAIR is NOT for treating asthma or sudden, severe symptoms of COPD. If you are a smoker, it is important to quit smoking.

    DA: 62 PA: 74 MOZ Rank: 88